{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:25:58Z","timestamp":1774416358053,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014810","name":"Normandy University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116975","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:47:00Z","timestamp":1729280820000},"page":"116975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"280","author":[{"given":"Christophe","family":"Rochais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Lecoutey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Lalut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Gaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy","family":"Largilli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rald","family":"N\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Corvaisier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Sopkova de Oliveira Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Since","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Freret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00eblle","family":"Callizot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Claeysen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Boulouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-615X","authenticated-orcid":false,"given":"Patrick","family":"Dallemagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejmech.2024.116975_bib1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/acschemneuro.2c00195","article-title":"Alzheimer's: the ABCDE Paradigm","volume":"13","author":"Gupta","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116975_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00292-3","article-title":"Immunotherapy for Alzheimer's disease: targeting \u03b2-amyloid and beyond","volume":"11","author":"Song","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116975_bib3","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116975_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer's disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116975_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116975_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ejmech.2024.116975_bib7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116975_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s40120-024-00604-x","article-title":"Donanemab in Japanese patients with early alzheimer's disease: subpopulation analysis of the TRAILBLAZER-ALZ 2 randomized trial","author":"Sato","year":"2024","journal-title":"Neurol. Ther"},{"issue":"36","key":"10.1016\/j.ejmech.2024.116975_bib9","doi-asserted-by":"crossref","first-page":"E3825","DOI":"10.1073\/pnas.1410315111","article-title":"Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment","volume":"111","author":"Lecoutey","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116975_bib10","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/acs.jmedchem.5b00115","article-title":"Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-ht4r) agonist activities as potential agents against Alzheimer's disease: the design of donecopride","volume":"58","author":"Rochais","year":"2015","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116975_bib11","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/bph.14964","article-title":"Donecopride, a Swiss army knife with potential against Alzheimer's disease","volume":"177","author":"Rochais","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116975_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116975_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnagi.2013.00096","article-title":"Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease","volume":"5","author":"Giannoni","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116975_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.dmpk.2015.10.003","article-title":"Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(\u2212\/\u2212) rats","volume":"31","author":"Nagaya","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2024.116975_bib15","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/ol800548t","article-title":"Benzyl protection of phenols under neutral conditions: palladium-catalyzed benzylations of phenols","volume":"15","author":"Kuwano","year":"2008","journal-title":"Org. Lett."},{"issue":"41","key":"10.1016\/j.ejmech.2024.116975_bib16","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1016\/j.tetlet.2007.08.030","article-title":"A simple method for chemoselective phenol alkylation","volume":"48","author":"Liu","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.116975_bib17","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1021\/ja00517a037","article-title":"Derivatives of 1-methoxy-3-trimethylsilyloxy-1,3-butadiene for diels-alder reactions","volume":"101","author":"Danishefsky","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116975_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejmech.2016.03.059","article-title":"Synthesis and evaluation of novel serotonin 4 receptor radiotracers for single photon emission computed tomography","volume":"116","author":"Lalut","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116975_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetyl-cholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116975_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-1161(83)90010-9","article-title":"Revised methods for the Salmonella mutagenicity test","volume":"113","author":"Maron","year":"1983","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2024.116975_bib21","series-title":"The R Project for Statistical Computing","year":"2016"},{"key":"10.1016\/j.ejmech.2024.116975_bib22","author":"Jaki"},{"key":"10.1016\/j.ejmech.2024.116975_bib23","first-page":"1727","article-title":"A new design for the screening of CNS-active drugs in mice","volume":"11","author":"Morpugo","year":"1971","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejmech.2024.116975_bib24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2012.02.012","article-title":"Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice","volume":"230","author":"Freret","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2024.116975_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02246579","article-title":"Effect of purines analogues on spontaneous alternation in mice","volume":"123","author":"Hooper","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2024.116975_bib26","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2024.116975_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2012.02.012","article-title":"Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT(4) receptor activation (RS67333) on object recognition in mice","volume":"230","author":"Freret","year":"2012","journal-title":"Behav. Brain Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:24:53Z","timestamp":1732170293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S0223523424008560"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116975","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116975"}}